Global Nicotinamide Riboside (NR) Supply, Demand and Key Producers, 2023-2029

Global Nicotinamide Riboside (NR) Supply, Demand and Key Producers, 2023-2029

The global Nicotinamide Riboside (NR) market size is expected to reach $ 38 million by 2029, rising at a market growth of 8.0% CAGR during the forecast period (2023-2029).

Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.

Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.

In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.

Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.

In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.

The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.

The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.

Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

This report studies the global Nicotinamide Riboside (NR) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nicotinamide Riboside (NR), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nicotinamide Riboside (NR) that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Nicotinamide Riboside (NR) total production and demand, 2018-2029, (MT)

Global Nicotinamide Riboside (NR) total production value, 2018-2029, (USD Million)

Global Nicotinamide Riboside (NR) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (MT)

Global Nicotinamide Riboside (NR) consumption by region & country, CAGR, 2018-2029 & (MT)

U.S. VS China: Nicotinamide Riboside (NR) domestic production, consumption, key domestic manufacturers and share

Global Nicotinamide Riboside (NR) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (MT)

Global Nicotinamide Riboside (NR) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (MT)

Global Nicotinamide Riboside (NR) production by Application production, value, CAGR, 2018-2029, (USD Million) & (MT).

This reports profiles key players in the global Nicotinamide Riboside (NR) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, Tiantai Biotechnology, EnzymeWorks, Suzhou MyLand Pharm & Nutrition and Shenzhen Ejion Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nicotinamide Riboside (NR) market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (US$/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Nicotinamide Riboside (NR) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Nicotinamide Riboside (NR) Market, Segmentation by Type
Purity ≤98%
Purity ＞98%

Global Nicotinamide Riboside (NR) Market, Segmentation by Application
Health Supplement
Pharmaceutical Additives

Companies Profiled:
ChromaDex
Genex Formulas
Shandong Tianming Pharmaceutical
Bontac
Longer Livetech
Tiantai Biotechnology
EnzymeWorks
Suzhou MyLand Pharm & Nutrition
Shenzhen Ejion Biotechnology
Zhejiang Jiahua
Weitai Pharmaceutical

Key Questions Answered

1. How big is the global Nicotinamide Riboside (NR) market?

2. What is the demand of the global Nicotinamide Riboside (NR) market?

3. What is the year over year growth of the global Nicotinamide Riboside (NR) market?

4. What is the production and production value of the global Nicotinamide Riboside (NR) market?

5. Who are the key producers in the global Nicotinamide Riboside (NR) market?